We are live on ! Find out more
ROSG

Rosetta Genomics Ltd.
ROSG

Delisted

ROSG was delisted on the 21st of May, 2018.

Back to rankings

1 hedge funds and large institutions have $1K invested in Rosetta Genomics Ltd. in 2021 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$1K – – –

ROSG Hedge Fund Activity: Q1 2021 in Review

1 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q1 2021, worth a combined $1K.

Fund positioning in ROSG was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Rosetta Genomics Ltd. (ROSG) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $1K of Rosetta Genomics Ltd. stock for Q1 2021.
  • 0 funds opened new Rosetta Genomics Ltd. positions in Q1 2021 and 0 closed out.

Based on aggregated 13F filings for Q1 2021.